Dec. 7, 2018—Research by Tim Meyer suggests that selective enforcement of trade rules in unexpected ways has penalized renewable industries while propping up those that rely on exhaustible natural resources.
Dec. 7, 2018—Research led by James Crowe, Jr., could lead to the first effective treatment for this dangerous mosquito-transmitted infection.
Dec. 7, 2018—The study will test the safety of a new cervical cancer vaccine for women who already have a significant presence of precancerous cells.
Dec. 7, 2018—A complete map of gene expression for the worm may help address broad questions in neuroscience about how gene expression programs establish diverse sets of neurons and how genetic differences contribute to neuronal function in healthy and disease conditions.
Ethan Lippmann wins inaugural $2.5M Chan Zuckerberg Initiative grant for neurodegenerative disorders research
Dec. 5, 2018—The five-year, $2.5 million award supports Ethan Lippmann's goal of better understanding how blood-brain barrier dysfunction impacts neurodegenerative diseases such as Alzheimer’s and Parkinson’s.
Dec. 4, 2018—The Vanderbilt Institute for Surgery and Engineering—dedicated to cross-disciplinary collaborations that advance discovery—will host a celebration and symposium at its new campus home Dec. 12.
Dec. 4, 2018—Changing the gut microbiome to beat illness really does hold great potential, but first scientists must answer what constitutes a healthy gut microbiome and in whom.
Nov. 30, 2018—Vanderbilt is developing an instructional approach that leverages students’ first language to comprehend English language texts more effectively.
Nov. 30, 2018—Vanderbilt will conduct a clinical trial of an intervention for young children with language delays in an NIDCD study.
Nov. 30, 2018—Researchers at Vanderbilt University Medical Center have identified a biomarker for insulin-producing beta cells. Their finding could lead to improved ways to study and treat diabetes.